Errors in Text, Figure, and End Matter

In the Original Contribution entitled “Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore”¹ published online in JAMA on March 3, 2020, there were errors in the text, a figure, and the end matter. In the second paragraph of the “Case Management” section in the text, the dose for coformulated lopinavir-ritonavir reported as 200 mg/100 mg should have been reported as 400 mg/100 mg. At the top right of Figure 1, “February 202” should have read “February 2020.” In the author affiliations, coauthor Kalimuddin should have appeared with coauthors Low, Anderson, T. Y. Tan, and Wang (all with Duke-NUS Medical School, Singapore). This article was corrected online.